Changing epidemiological features of hepatocellular carcinoma: Taiwan's position
Liver Int
.
2022 Dec;42(12):2911.
doi: 10.1111/liv.15442.
Epub 2022 Oct 6.
Authors
Teh-Ia Huo
1
2
3
,
Shu-Yein Ho
2
4
,
Po-Hong Liu
5
Affiliations
1
Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
2
School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
3
Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
4
Division of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan, Taiwan.
5
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
PMID:
36200486
DOI:
10.1111/liv.15442
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Carcinoma, Hepatocellular* / epidemiology
Humans
Liver Neoplasms* / epidemiology
National Health Programs
Taiwan / epidemiology